WHO Pharmaceuticals Newsletter 1998, No. 09&10
(1998; 23 pages)
Table des matières
Ouvrir ce répertoire et afficher son contenuRegulatory decisions
Ouvrir ce répertoire et afficher son contenuDrug surveillance
Ouvrir ce répertoire et afficher son contenuNew developments
Ouvrir ce répertoire et afficher son contenuMedical devices
Ouvrir ce répertoire et afficher son contenuGeneral information
Ouvrir ce répertoire et afficher son contenuMedication errors
Fermer ce répertoireVeterinary medicine
Afficher le documentClenbuterol-containing veterinary medicines - suspension of indication extended: Germany
Afficher le documentIpronidazole in veterinary medicines - marketing authorization revoked: carcinogenicity: Germany
Afficher le documentLabelling of drugs for use in milk- producing animals - revised regulations: final rule: USA
 

Labelling of drugs for use in milk- producing animals - revised regulations: final rule: USA

United States of America. The Food and Drug Administration has amended the new animal drug regulations to remove the existing 96-hour withdrawal time limitation, eliminate the requirement to calculate and label on the basis of the number of 12-hour milking periods that have elapsed since treatment, and to permit a milk-discard or withdrawal time to be calculated by elapsed hours since treatment.

The agency has taken these actions to allow greater flexibility in the labelling of new animal drugs for use in milk-producing animals. The increased flexibility will make it easier and more economical for sponsors to comply with the regulations.

[See also Pharmaceuticals Newsletter No. 9, September 1996]

References: Federal Register 63(116): 32978-80 (1998).

For any technical enquiries related to the EDM Medicines Web site, please send an email to edmwebadmin@who.int

vers la section précédente
 

Dernière mise à jour: le 3 mai 2013